Physician profile
Farshid Amir
NPI 1639189681
$11,639.43
in general payments reported to CMS, 2019-2025
24 companies · $799 in 2025
The $799 reported for 2025 was more than what 87% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,165 · 2020: $500 · 2021: $1,050 · 2022: $605 · 2023: $3,403 · 2024: $2,117 · 2025: $799.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,755 · Food and Beverage: $2,663 · Consulting Fee: $600 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,755.20 |
| Food and Beverage | $2,663.42 |
| Consulting Fee | $600.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $5,245.81 | 2019-2025 | Air Optix, Dailies Aqua Comfort Plus, Dailies Total1 Multifocal |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,744.08 | 2019-2021 | |
| Coopervision INC. | $1,212.79 | 2019-2025 | Clariti Contact Lens, Myday Contact Lens, Misight Contact Lens |
| Johnson & Johnson Vision Care, INC. | $767.94 | 2019-2025 | Acuvue |
| Abbvie INC. | $348.35 | 2022-2025 | Durysta, Vuity |
| Biotissue Holdings INC. | $281.86 | 2023 | |
| Apellis Pharmaceuticals, INC. | $249.22 | 2024 | Syfovre |
| Astellas Pharma US INC | $243.98 | 2023 | Izervay |
| Visioneering Technologies, INC. | $222.62 | 2019-2025 | |
| Optos, INC. | $197.96 | 2019-2021 | |
| Glaukos Corporation | $176.90 | 2021-2024 | Ce-Marked Kxla System |
| Bausch & Lomb Americas INC. | $158.54 | 2023-2025 | Miebo, Scoutpro Osmolarity System |
| Novartis Pharmaceuticals Corporation | $130.12 | 2021 | |
| Carl Zeiss Meditec, INC. | $125.64 | 2020 | |
| Horizon Therapeutics Plc | $124.99 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $64.28 | 2025 | |
| Ocular Therapeutix, INC. | $62.50 | 2020 | |
| Sight Sciences, INC. | $56.29 | 2020 | |
| Abb Con-Cise Optical Group LLC | $51.48 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $48.00 | 2020 | |
| Rxsight INC | $47.30 | 2021 | |
| Oyster Point Pharma, INC. | $31.86 | 2022 | |
| Allergan, INC. | $23.53 | 2021 | |
| Sun Pharmaceutical Industries INC. | $23.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farshid Amir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.